申请人:SmithKline Beckman Corporation
公开号:US04454065A1
公开(公告)日:1984-06-12
Prodrugs are described whose structures have a oligopeptide chain which is substituted by a nucleophilic chemotherapeutic residue at the .alpha.-position. The products have increased cell membrane permeability and beneficial physico-chemical properties.
描述了结构中含有寡肽链的前药,该链在α位点被亲核化疗残基取代。这些产物具有增加的细胞膜渗透性和有益的物理化学性质。